SFM
IRWD icon

Signet Financial Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Signet Financial Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,640
Closed -$31K – 758
2021
Q4 		$31K Buy
+2,640
New +$32.4K ﹤0.01% 683

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Signet Financial Management's IRWD Position: Q1 2022 in Review

Signet Financial Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2022, closing a stake of 2,640 shares — an estimated $31K sold.

Signet Financial Management first reported a position in IRWD in Q4 2021 and held it in 1 quarter. The position peaked at $31K in Q4 2021. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

  • Signet Financial Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 2,640 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $31K.
  • Signet Financial Management first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Signet Financial Management's Ironwood Pharmaceuticals position peaked at $31K in Q4 2021.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.